The DDB Public Hearings Committee in Session during the discussion on the inclusion of Gamma Butyro-Lactone (GBL) in the list of Dangerous Drugs - SPIK
Dangerous Drugs Board (DDB) Public Hearing on the Inclusion of Gamma Butyro Lactone (GBL) in the list of dangerous Drugs
DDB Public Hearings Committee , Gamma Butyro-Lactone, Dangerous Drugs
17037
post-template-default,single,single-post,postid-17037,single-format-standard,bridge-core-1.0.5,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

The DDB Public Hearings Committee in Session during the discussion on the inclusion of Gamma Butyro-Lactone (GBL) in the list of Dangerous Drugs

DDB

14 Mar The DDB Public Hearings Committee in Session during the discussion on the inclusion of Gamma Butyro-Lactone (GBL) in the list of Dangerous Drugs

Posted at 04:14h in Featured News, RC News by
Spread the love

Dangerous Drugs Board (DDB) Public Hearing on the Inclusion of Gamma Butyro Lactone (GBL) in the list of dangerous Drugs – February 6, 2017, DDB-PDEA Bldg., NIA Site, National Government Center, East Triangle, Q.C.